期刊
JOURNAL OF MOLECULAR DIAGNOSTICS
卷 15, 期 2, 页码 149-157出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jmoldx.2012.09.004
关键词
-
类别
资金
- On-Q-ity Inc.
Circulating tumor cells (CTCs) are shed from cancerous tumors, enter the circulatory system, and migrate to distant organs to form metastases that ultimately lead to the death of most patients with cancer. Identification and characterization of CTCs provides a means to study, monitor, and potentially interfere with the metastatic process. Isolation of CTCs from blood is challenging because CTCs are rare and possess characteristics that reflect the heterogeneity of cancers. Various methods have been developed to enrich CTCs from many millions of normal blood cells. Microfluidics offers an opportunity to create a next generation of superior CTC enrichment devices. This review focuses on various microfluidic approaches that have been applied to date to capture CTCs from the blood of patients with cancer. (J Mol Diagn 2013, 15: 149-157; http://dx.doi.org/10.1016/j.jmoldx.2012.09.004)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据